# James O. Lindsay

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-o-lindsay/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,663 |
| Field | Inflammatory Bowel Disease |
| h-index | 72 |
| i10-index | 170 |
| Last Known Institution | Queen Mary University of London |
| OpenAlex ID | https://openalex.org/A5055734737 |
| ORCID iD | https://orcid.org/0000-0003-3353-9590 |
| Works | 442 |

## Researcher papers

- [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management](https://scholariq.org/papers/second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of-2/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study](https://scholariq.org/papers/predictors-of-anti-tnf-treatment-failure-in-anti-tnf-naive-patients-with-active/)
- [A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial](https://scholariq.org/papers/a-diet-low-in-fodmaps-reduces-symptoms-in-patients-with-irritable-bowel-syndrome/)
- [HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease](https://scholariq.org/papers/hla-dqa1-05-carriage-associated-with-development-of-anti-drug-antibodies-to/)
- [Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial](https://scholariq.org/papers/effects-of-low-fodmap-diet-on-symptoms-fecal-microbiome-and-markers-of/)
- [A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial](https://scholariq.org/papers/a-biomarker-stratified-comparison-of-top-down-versus-accelerated-step-up/)
- [Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting](https://scholariq.org/papers/management-of-patients-with-crohn-s-disease-and-ulcerative-colitis-during-the/)
- [Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies](https://scholariq.org/papers/serologic-response-to-messenger-rna-coronavirus-disease-2019-vaccines-in/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)

## Researcher university

- [Queen Mary University of London](https://scholariq.org/institutions/queen-mary-university-of-london/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.